Irinotecan (CPT-11): pharmacology and clinical applications

Crit Rev Oncol Hematol. 1996 Sep;24(1):3-26. doi: 10.1016/1040-8428(96)00201-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic* / pharmacology
  • Antineoplastic Agents, Phytogenic* / therapeutic use
  • Camptothecin / analogs & derivatives*
  • Camptothecin / pharmacology
  • Camptothecin / therapeutic use
  • Clinical Trials as Topic
  • Humans
  • Irinotecan
  • Neoplasms / drug therapy*
  • Neoplasms, Experimental / drug therapy*

Substances

  • Antineoplastic Agents, Phytogenic
  • Irinotecan
  • Camptothecin